Joanna Metzner-Sadurski, President of Oncology101.org, Adjunct Professor at Edward Via College of Osteopathic Medicine, shared on LinkedIn:
“I truly enjoyed the ACCC workshop on bringing CAR T-cell therapy into the community. These conversations are so important, and Caroline Offit, MS did an excellent job moderating the discussion.
Thank you to the outstanding presenters—Dr. Natalie Grover, Dr. Tatjana Grgic, Kathleen Prudhomme, and Ruiling Yuan, —for sharing their expertise on the evolving CAR T-cell treatment landscape, preparing community teams to manage patients after therapy, shared decision-making, and collaborative care following treatment.
Health literacy must remain central to every conversation about CAR T-cell therapy. Nurses are essential partners in helping patients and their families understand what CAR T-cell therapy is, what the treatment process involves, which symptoms and side effects to monitor, what information to record, and when to contact the care team.
That is exactly why we developed Oncology101.org. Our CAR T-cell therapy educational resource provides patients with clear, understandable information before they begin treatment. This helps them come to appointments better prepared, ask informed questions, actively participate in conversations with their care team, and understand what lies ahead.
Education does not replace the patient-care team. It strengthens communication and helps patients feel more informed, prepared, and empowered throughout their treatment journey.”
Other posts featuring Joanna Metzner-Sadurski on OncoDaily.
